| New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation |
Globe Newswire |
11/02 |
08:00 |
| Terra Balcanica Spin Off Terra North Resources Identifies Additional Uranium Targets over Fontaine lake, Saskatchewan |
Globe Newswire |
11/02 |
08:00 |
| Radiopharm Theranostics Reports Business Update |
Globe Newswire |
11/02 |
08:00 |
| Fusemachines Launches New Video Series Showcasing Technology Maturity of HireFoundry.ai's Real-Time Interview Agent |
Globe Newswire |
11/02 |
08:00 |
| Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets |
Globe Newswire |
11/02 |
08:00 |
| Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026 |
Globe Newswire |
11/02 |
08:00 |
| CytomX Therapeutics to Present at Upcoming November Investor Conferences |
Globe Newswire |
11/02 |
08:00 |
| Steric Systems Announces NMR Study Showing Changes in Beverage Molecular Interactions |
Globe Newswire |
11/02 |
08:00 |
| Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China |
Globe Newswire |
11/02 |
08:00 |
| Syntec Optics (Nasdaq: OPTX) Secures 25% Order Increase for Advanced Space Reconnaissance |
Globe Newswire |
11/02 |
08:00 |
| Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective |
Globe Newswire |
11/02 |
08:00 |
| UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer |
Globe Newswire |
11/02 |
08:00 |
| AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry |
Globe Newswire |
11/02 |
08:00 |
| Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data |
Globe Newswire |
11/02 |
08:00 |
| ASML reports transactions under its current share buyback program |
Globe Newswire |
11/02 |
08:00 |
| Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences |
Globe Newswire |
11/02 |
08:00 |
| Eyconis to Participate in Upcoming Investor Conferences |
Globe Newswire |
11/02 |
08:00 |
| Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.095 per Share for November 2026 |
Globe Newswire |
11/02 |
07:50 |
| Honeywell Aerospace Inc. Class Action Reminder – Robbins LLP Encourages HONA Investors with Large Losses to Contact the Firm for Information About Their Rights |
Globe Newswire |
11/02 |
07:42 |
| HiBob and HR Chief Invite Senior HR Leaders to Exclusive Private Executive Dinners in London |
Globe Newswire |
11/02 |
07:34 |
| Trekor to Release Third Quarter 2026 Results |
Globe Newswire |
11/02 |
07:30 |
| Cognition Therapeutics to Host Third Quarter 2026 Financial Results and Business Update Call on November 5, 2026 |
Globe Newswire |
11/02 |
07:30 |
| Foremost Clean Energy Announces Commencement of Inaugural Drill Program at the Turkey Lake Property |
Globe Newswire |
11/02 |
07:30 |
| Crescent Biopharma to Present at November Investor Conferences |
Globe Newswire |
11/02 |
07:30 |
| Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies |
Globe Newswire |
11/02 |
07:30 |
